Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Anonima Materie Sintetiche and Affini (AMSA) Spa

02 1HAS Healthcare Advanced Synthesis SA

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Peptide Therapy Summit
Not Confirmed
arrow
arrow
Peptide Therapy Summit
Not Confirmed

CYSTEAMINE HYDROCHLORIDE

NDC Package Code : 17373-1330

Start Marketing Date : 2022-02-23

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

Peptide Therapy Summit
Not Confirmed
arrow

Looking for 156-57-0 / Cysteamine Hydrochloride API manufacturers, exporters & distributors?

Cysteamine Hydrochloride manufacturers, exporters & distributors 1

60

PharmaCompass offers a list of Cysteamine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cysteamine Hydrochloride manufacturer or Cysteamine Hydrochloride supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cysteamine Hydrochloride manufacturer or Cysteamine Hydrochloride supplier.

PharmaCompass also assists you with knowing the Cysteamine Hydrochloride API Price utilized in the formulation of products. Cysteamine Hydrochloride API Price is not always fixed or binding as the Cysteamine Hydrochloride Price is obtained through a variety of data sources. The Cysteamine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Cysteamine Hydrochloride

Synonyms

156-57-0, 2-aminoethanethiol hydrochloride, Cysteamine hcl, 2-mercaptoethylamine hydrochloride, Mercaptamine hydrochloride, Bekaptan

Cas Number

156-57-0

Unique Ingredient Identifier (UNII)

IF1B771SVB

About Cysteamine Hydrochloride

A mercaptoethylamine compound that is endogenously derived from the COENZYME A degradative pathway. The fact that cysteamine is readily transported into LYSOSOMES where it reacts with CYSTINE to form cysteine-cysteamine disulfide and CYSTEINE has led to its use in CYSTINE DEPLETING AGENTS for the treatment of CYSTINOSIS.

Cysteamine HCl Manufacturers

A Cysteamine HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cysteamine HCl, including repackagers and relabelers. The FDA regulates Cysteamine HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cysteamine HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Cysteamine HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Cysteamine HCl Suppliers

A Cysteamine HCl supplier is an individual or a company that provides Cysteamine HCl active pharmaceutical ingredient (API) or Cysteamine HCl finished formulations upon request. The Cysteamine HCl suppliers may include Cysteamine HCl API manufacturers, exporters, distributors and traders.

click here to find a list of Cysteamine HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Cysteamine HCl NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cysteamine HCl as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Cysteamine HCl API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Cysteamine HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Cysteamine HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cysteamine HCl NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Cysteamine HCl suppliers with NDC on PharmaCompass.

Cysteamine HCl Manufacturers | Traders | Suppliers

Cysteamine HCl Manufacturers, Traders, Suppliers 1
49

We have 2 companies offering Cysteamine HCl

Get in contact with the supplier of your choice:

  1. Amsa Spa
  2. HAS Healthcare Advanced Synthesis
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.